KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Invested Capital (2016 - 2025)

Historic Invested Capital for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $8.7 billion.

  • Bio-Rad Laboratories' Invested Capital rose 1141.49% to $8.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 billion, marking a year-over-year increase of 1141.49%. This contributed to the annual value of $8.7 billion for FY2025, which is 1141.49% up from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Invested Capital is $8.7 billion, which was up 1141.49% from $7.9 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Invested Capital registered a high of $15.3 billion during Q3 2021, and its lowest value of $7.8 billion during Q4 2024.
  • Its 5-year average for Invested Capital is $10.0 billion, with a median of $9.8 billion in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 6575.46% in 2021, then plummeted by 3696.63% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Invested Capital stood at $13.7 billion in 2021, then fell by 21.06% to $10.8 billion in 2022, then decreased by 8.07% to $9.9 billion in 2023, then fell by 21.76% to $7.8 billion in 2024, then increased by 11.41% to $8.7 billion in 2025.
  • Its last three reported values are $8.7 billion in Q4 2025, $7.9 billion for Q3 2025, and $8.3 billion during Q2 2025.